期刊文献+

移植肾早期血管性排斥对晚期排斥发生的影响 被引量:4

The influence of early vascular rejection on late rejection in first cadaveric renal transplantation
原文传递
导出
摘要 目的 探讨肾移植术后早期发生的血管性排斥逆转后对晚期排斥发生的影响。方法回顾性分析自 1988年 5月至 2003年 3月在本中心进行首次单纯尸体肾移植病例 1062例。根据术后1个月内有无发生血管性排斥情况,分为血管性排斥组(45例)与无血管性排斥组(1017例)。随访至少 6个月,比较术后 1月以后两组排斥发生率情况。结果 两组在受体移植时年龄、性别比例、淋巴毒、冷 /热缺血时间、免疫抑制剂方案及随访期间血清肌酐浓度无统计学差异。血管性排斥组排斥逆转后总的排斥发生率为 2 .22% (1 /45), 无血管性排斥组为 12. 59% (128 /1017),两组有显著统计学差异(P=0 .034)。结论 完全逆转的早期血管性排斥可以降低其后排斥的发生率。 Objective To explore the influence of early completely reversal vascular rejection on late rejection Methods The data of 1062 patients who received their first cadaveric transplants between May 1988 and March 2003 were analyzed respectively The patients were divided into 2 groups: group with vascular rejection occurring within 1 month postoperatively ( n =45), and group without vascular rejection ( n =1017) Follow up was performed for at least 6 months The influence of demographic characteristics (transplant age, sex), transplant variables (complement dependent cytotoxity test, cold /warm ischemia time), and post transplant variables ( immunosuppressive agents for the prevention of acute rejection,) were analyzed Results There were no differences in the age at transplantation, sex, complement dependent cytotoxity test, cold/warm ischemia time, immunosuppression agent protocol, and serum creatinine during follow up between the recipients of these two groups Late rejection, including acute interstitial rejection, borderline rejection, and chronic rejection, occurring one month after transplantation was 2 22%(1/45)in the vascular rejection group, significantly lower than that of the no vascular rejection group (12 59%, 128/1017, P =0 034) Conclusion Early completely reversal vascular rejection can reduce the rate of late rejection
出处 《中华医学杂志》 CAS CSCD 北大核心 2005年第5期332-334,共3页 National Medical Journal of China
关键词 血管性 早期 逆转 发生率 晚期 排斥 移植肾 浓度 性别比例 病例 Immunosuppression Vascular rejection Kidney renal transplant
  • 相关文献

参考文献14

  • 1陈江华,何强,王逸民,吴建永,寿张飞,王慧萍.移植肾早期血管性排斥治疗的临床研究[J].中华肾脏病杂志,2001,17(2):119-122. 被引量:15
  • 2吴建永,陈江华,王逸民,张建国,朱琮,王苏娅,张萍,黄洪锋,何强.完全逆转的急性排斥对移植肾长期生存率的影响[J].中华医学杂志,2003,83(2):106-109. 被引量:11
  • 3Basadonna GP, Matas AJ, Gillingham KJ, et al. Early versus late acute renal allograft rejection: impact on chronic rejection. Transplantation,1993, 55: 993-995.
  • 4Vereerstraeten P, Abramowicz D, de Pauw L, et al. Absence of deleterious effect on long-term kidney graft survival of rejection episodes with complete functional recovery. Transplantation, 1997, 63: 1739-1743.
  • 5Matas AJ, Gillingham KJ, Payne WD, et al. The impact of an acute rejection episode on long-term renal allograft survival (t1/2). Transplantation, 1994, 57: 857-859.
  • 6Gaber LW, Schroeder TJ, Moore LW, et al. The correlation of Banff scoring with reversibility of first and recurrent rejection episodes. Transplantation, 1996, 61: 1711-1715.
  • 7Regele H, Bohmig GA. Tissue injury and repair in allografts: novel perspectives. Curr Opin Nephrol Hypertens, 2003, 12: 259-266.
  • 8Xu W, Baelde HJ, Lagaaij EL, et al. Endothelial cell chimerism after renal transplantation in a rat model. Transplantation, 2002, 74: 1316-1320.
  • 9Lagaaij EL, Cramer-Knijnenburg GF, van Kemenade FJ, et al. Endothelial cell chimerism after renal transplantation and vascular rejection. Lancet, 2001, 357: 33-37.
  • 10van Saase JL, van der Woude FJ, Thorogood J, et al. The relation between acute vascular and interstitial renal allograft rejection and subsequent chronic rejection. Transplantation, 1995, 59: 1280-1285.

二级参考文献18

  • 1Peeters J, Roels L, Vanrenterghem Y. Chronic renal allograft failure: clinical overview. Kidney Int, 1995, 48:S97-S101.
  • 2Monaco AP, Burke JF, Ferguson RM, et al. Current thinking on chronic renal allograft rejection: issues, concerns, and recommendations from a 1997 roundtable discussion. Am J Kidn Dis, 1999,33:150-160.
  • 3Yves Vanrenterghem. Impact of acute rejection on the long-term outcome after renal transplantation. Graft, 2000, 3:31-33.
  • 4Almond PS, Matas A, Gillingham K, et al. Risk factors for chronic rejection in renal allograft recipients. Transplantation, 1993 ,55:752-756.
  • 5Flechner SM, Modlin CS, Serrano DP, et al. Determinants of chronic renal allograft rejection in cyclosporine-treated recipients. Transplantation, 1996,15;62:1235-1241.
  • 6Joseph JT, Kingsmore DB, Junor BJ, et al. The impact of late acute rejection after cadaveric kidney transplantation. Clin Transplant, 2001 ,15:221-227.
  • 7Pelletier RP, Cosio F, Henry ML, et al. Acute rejection following renal transplantation. Evidence that severity is the best predictor of subsequent graft survival time. Clin Transplant, 1998,12:543-552.
  • 8Heaf JG, Ladefoged J. The effect of acute rejection on long-term renal graft survival is mainly related to initial renal damage. Transplant Int, 1998,11:S26-S31.
  • 9Tanabe K, Ishikawa N, Tokumoto T, et al. Factors affecting long-term renal allograft survival in cyclosporine-treated kidney transplants. Transplant Proc, 1998 ,30:1805-1809.
  • 10Ishikawa A, Flechner SM, Goldfarb DA, et al. Quantitative assessment of the first acute rejection as a predictor of renal transplant outcome. Transplantation, 1999,68:1318-1324.

共引文献22

同被引文献50

  • 1王超.多器官功能障碍综合征病死率[J].临床和实验医学杂志,2006,5(1):43-44. 被引量:14
  • 2周绍棠,阎冀焕,杨成,曾宁,吴轲,陈忠华.血清蛋白质指纹图谱构建及对慢性移植物肾病病人的早期诊断意义[J].中华医学杂志,2006,86(28):1966-1969. 被引量:4
  • 3Billingham ME, Cary NRB, Hammond ME, et al. A working for mulation for the standardization of nomenclature in the diagnosis of heart and lung rejection. J Heart Lung Transplant, 1990, 9 : 587-593.
  • 4Mosmann TR, Cherwinski HM, Bond MW, et al. Two types of murine helper T cell clone. Ⅰ. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol, 1986, 136:2348-2357.
  • 5Woodward JE, Bayer AL, Baliga P. Enhanced allograft survival via simultaneous blockade of transferrin receptor and interleukin-2 receptor. Transplantation, 1999, 8 : 1369-1376.
  • 6Lietz K, John R, Beniaminovitz A, et al. Interleukin-2 receptor blockade in cardiac transplantation: influence of HLA-DR locus incompatibility on treatment efficacy. Transplantation, 2003, 75:781-787.
  • 7Webster AC, Playford EG, Higgins G, et al. interleukin 2 receptor antagonists for renal transplant recipients: a meta-analysis of randomized trials. Transplantation, 2004, 77 : 166-176.
  • 8van Gelder T, Baan CC, Balk AHMM, et al. Blockade of the interleukin(IL) -2/IL-2 receptor pathway with a monoclonal anti-IL-2 receptor antibody( BT563 ) does not prevent the development of acute heart allograft rejection in humans. Transplantation, 1998, 65:405-410.
  • 9Li XC, Roy-Chaudhury P, Hancock WW, et al. IL-2 and IL-4 double knockout mice reject islet allografts: a role for novel T cell growth factors in allograft rejection. J Immunol, 1998, 161:890-896.
  • 10Grabstein KHJ, Eisenman K, Shanebeck D, et al. Cloning of a T cell growth factor that interacts with the β-chain of the interleukin-2 receptor. Science, 1994, 264:965-968.

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部